东诚药业(002675.SZ)所属子公司蓝纳成递交H股发行上市申请

Core Viewpoint - Dongcheng Pharmaceutical (002675.SZ) announced that its subsidiary, Yantai Lanacheng Biotechnology Co., Ltd. (referred to as "Lanacheng"), has submitted application materials for an initial public offering (IPO) and listing on the main board of the Hong Kong Stock Exchange, with the information published on the exchange's website [1] Group 1 - Dongcheng Pharmaceutical's subsidiary Lanacheng is pursuing an IPO in Hong Kong [1] - The application materials have been officially submitted to the Hong Kong Stock Exchange [1] - The announcement has been made public through the exchange's website [1]